Older patients with depressive and anxiety disorders are susceptible to the age-related acute and chronic brain and physical illnesses, including metabolic, endocrine and neurobiological disorders,1 and are at high risk for cardiovascular, and cerebrovascular comorbidities.2 The significant heterogeneity in geriatric depression results in difficulties in both comparing research findings and identifying biomarkers to establish homogeneous subgroups for depression personalized therapy.3 Since oxidative stress is associated with depression,4 it is reasonable to search for such biomarkers among antioxidant systems, i.e
The result is a peptide with a half-life of 159 to 195 hours, roughly 7 to 8 days, making once-weekly administration possible
Dose Titration Strategy to Reduce All GI Effects Slower titration is the most evidence-supported method for reducing GI side effects without sacrificing efficacy
These stable levels allow the medication to continuously regulate appetite, blood sugar, and metabolism
Many people have genetic mutations or health conditions which can disrupt these processes, making it difficult for the body to utilize B12 effectively